Skip to main content
OpenTrials
Completed

NCT Number: NCT01447173

Vitamin and Asthma Study

The study looks at how vitamin D supplement will improve the severity of asthma and lung function as well as biomarkers in asthmatic children.

Completed

Looking for future studies?

Notify Me

Key information

Age range

7 year–17 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Pediatrics Allergy Clinic at Georgia Health Sciences University

Augusta, Georgia, 30912, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • History of asthma (under control)otherwise in good general health

Exclusion criteria

  • Poorly controlled asthma
  • Taking daily multivitamin or vitamin D supplementation
  • Taking oral steroid medication
  • History of bronchopulmonary dysplasia or chronic lung disease, extreme prematurity, congenital heart disease, significant renal dysfunction or primary kidney disease, endocrinologic abnormalities of calcium metabolism or parathyroid disorders

Treatment and study plan

Vitamin D

Drug

Vitamin D 2000 IU daily pill Vitamin D 400 IU daily pill

Primary outcomes

  1. Change in Pulmonary Function Test (PFT) after vitamin D supplementation

    Time frame: 4 weeks

  2. Change in Asthma Control Test (ACT) scores after vitamin D supplementation

    Time frame: 4-week

Sponsors and collaborators

Lead sponsor

Augusta University

Other

Registry information

Important dates

Study start
2010
Primary completion
2011
Study completion
2011
First posted
Oct 6, 2011
Registry last updated
Oct 23, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.